Merit Financial Group, LLC Neurocrine Biosciences Inc Transaction History
Merit Financial Group, LLC
- $6.49 Billion
- Q1 2025
A detailed history of Merit Financial Group, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Merit Financial Group, LLC holds 4,153 shares of NBIX stock, worth $421,031. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,153
Previous 3,808
9.06%
Holding current value
$421,031
Previous $519,000
11.56%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
95.9MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.44 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.03 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$496 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$306 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$257 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $9.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...